Back to Search
MITCHELL MACHTAY, M.D.
M.D.
Radiation Oncology Physician
NPI: 1528081437IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
35-094475(OH)MD-045031-L(PA)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 1989
Research & Publications (20)
Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer.
PMID 19107945·Head Neck·2009
8-other
Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.
PMID 18559875·J Clin Oncol·2008
8-other
Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
PMID 17716826·Int J Radiat Oncol Biol Phys·2007
2-rct
Systemic polyethylene glycol-modified (PEGylated) superoxide dismutase and catalase mixture attenuates radiation pulmonary fibrosis in the C57/bl6 mouse.
PMID 17069914·Radiother Oncol·2006
7-preclinical
Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience.
PMID 15927409·Int J Radiat Oncol Biol Phys·2005
3-trial
Pilot study of accelerated radiotherapy with concurrent chemotherapy for stage III non-small cell lung cancer.
PMID 16015530·Semin Oncol·2005
3-trial
Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
PMID 15093901·Int J Radiat Oncol Biol Phys·2004
8-other
Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
PMID 14752420·J Thorac Cardiovasc Surg·2004
4-observational
Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial.
PMID 12351593·J Clin Oncol·2002
3-trial
Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma.
PMID 11579111·J Clin Oncol·2001
8-other
Pilot study of organ preservation multimodality therapy for locally advanced resectable oropharyngeal carcinoma.
PMID 11039514·Am J Clin Oncol·2000
3-trial
Daily image guidance with cone-beam computed tomography for head-and-neck cancer intensity-modulated radiotherapy: a prospective study.
PMID 19540071·Int J Radiat Oncol Biol Phys·2010
8-other
Report on a randomized trial comparing two forms of immobilization of the head for fractionated stereotactic radiotherapy.
PMID 19235368·Med Phys·2009
4-observational
Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies.
PMID 19084346·Int J Radiat Oncol Biol Phys·2009
3-trial
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.
PMID 19410717·Lancet·2009
1-meta
Celebrating 40 years of clinical inquiry: The RTOG'S ruby anniversary.
PMID 18474307·Int J Radiat Oncol Biol Phys·2008
8-other
Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
PMID 18501528·Int J Radiat Oncol Biol Phys·2008
8-other
Radiation treatment breaks and ulcerative mucositis in head and neck cancer.
PMID 18701763·Oncologist·2008
6-review
New advances in high-technology radiotherapy for head and neck cancer.
PMID 19010266·Hematol Oncol Clin North Am·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 500 UNIVERSITY DR
HERSHEY, PA 17033 - Phone
- (800) 243-1455
Quick Facts
- NPI
- 1528081437
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile